4

OWNERSHIP DOCUMENT

Company: Viridian Therapeutics, Inc.\DE
Filed: October 27, 2025
Period of Report: October 23, 2025
Accession Number: 0001104659-25-102606

View Document ↗ View on SEC.gov ↗